Kelli Cole

PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation

A. Samer Al‐Homsi, Frank Cirrone, Stephanie Wo et al. · Blood Advances · 2023 · 34 citations · Full text

Short Course of Post-Transplantation Cyclophosphamide and Bortezomib for Graft-versus-Host Disease Prevention after Allogeneic Peripheral Blood Stem Cell Transplantation Is Feasible and Yields Favorable Results: A Phase I Study

Ahmad-Samer Al-Homsi, Kelli Cole, Marlee Bogema et al. · Biology of Blood and Marrow Transplantation · 2015 · 17 citations · Full text

Post-transplantation High-dose Cyclophosphamide, Cell Therapy, Transplantation +14

Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either Agent Alone

Ahmad Samer Al-Homsi, Austin Goodyke, Michael J. McLane et al. · Biology of Blood and Marrow Transplantation · 2016 · 14 citations

Calcineurin and mTOR Inhibitor–Free Post-Transplantation Cyclophosphamide and Bortezomib Combination for Graft-versus-Host Disease Prevention after Peripheral Blood Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I/II Study

A. Samer Al‐Homsi, Kelli Cole, Marlee Muilenburg et al. · Biology of Blood and Marrow Transplantation · 2017 · 14 citations · Full text

Ixazomib suppresses human dendritic cell and modulates murine graft-versus-host disease in a schedule-dependent fashion

Ahmad Samer Al-Homsi, Austin Goodyke, Kelli Cole et al. · Experimental Hematology · 2016 · 10 citations

Inflammation, Transplantation, Autoimmune Disease +12